Yttrium 90–Labeled Ibritumomab Tiuxetan Radioimmunotherapy Produces High Response Rates and Durable Remissions in Patients with Previously Treated B-Cell Lymphoma

Leo I. Gordon, Christine A. White, Arturo Molina et al.|Clinical Lymphoma|2004

Cited by 121